Middle East & Africa Active Medical Implantable Devices Market, By Product (Cardiac Resynchronization Therapy Devices (CRT-D), Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Eye Implants, Neurostimulators, Active Implantable Hearing Devices, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop recorders, Brachytheraphy, Implantable Glucose Monitors, Dropped Foot Implants, Shoulder Implants, Implantable Infusion Pumps, and Implantable Accessories), Surgery Type (Traditional Surgical Methods and Minimally Invasive Surgery), Procedure (Neurovascular, Cardiovascular, Hearing, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Clinics), Country (South Africa and Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Middle East and Africa Active Medical Implantable Devices Market
Middle East & Africa active medical implantable devices market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyzes that the market is growing with a CAGR of 4.6% in the forecast period of 2021 to 2028 and is expected to reach USD 945.75 million by 2028. Rising disposable incomes and increase in new product development are the major drivers boosting the growth of the market in the forecast period. Presence of major market players are providing a great opportunity for the market to grow. However, high cost of implantable devices are challenging the market growth.
Active implantable medical devices are powered devices that are inserted into a patient’s body by surgical procedure and are intended to remain in the patient’s body after the procedure.
The market for these devices is expected to grow increase in R&D activities and new product launches by the manufactures. However, limitation associated harmful side effects and cost is expected to restrain the market growth in the forecast period.
The Middle East & Africa active medical implantable devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Middle East & Africa Active Medical Implantable Devices Market Scope and Market Size
The Middle East & Africa active medical implantable devices market is segmented on the basis of product, surgery type, procedure, end users.
- On the basis of product, the Middle East and Africa active medical implantable devices market is segmented into Cardiac Resynchronization Therapy Devices (CRT-D), implantable cardioverter defibrillators, implantable cardiac pacemakers, eye implants, neurostimulators, active implantable hearing devices, ventricular assist devices, implantable heart monitors/ insertable loop recorders, brachytheraphy, implantable glucose monitors, dropped foot implants, shoulder implants, implantable infusion pumps and implantable accessories. In 2021, Cardiac Resynchronization Therapy Devices (CRT-D) segment is expected to dominate the market as its efficiency and results are accurate.
- On the basis of surgery type, the Middle East and Africa active medical implantable devices market is segmented into traditional surgical methods and minimally invasive surgery. In 2021, traditional surgical methods segment is expected to dominate the market as it have less complication and expense of the treatment.
- On the basis of procedure, the Middle East and Africa active medical implantable devices market is segmented into neurovascular, cardiovascular, hearing and others. In 2021, cardiovascular is expected to dominate the market with the increase in cardiovascular disease.
- On the basis of end-users, the Middle East and Africa active medical implantable devices market is segmented into hospitals, specialty clinics, ambulatory surgical centers and clinics. In 2021, hospital segment is expected to dominate the market due growing demand of active medical implantable devices there.
Middle East & Africa Active Medical Implantable Devices Market Country Level Analysis
The active medical implantable devices market is analyzed and market size information is provided on the basis of product, surgery type, procedure, and end users.
The countries covered in the Middle East & Africa active medical implantable devices market report are the South Africa and Rest of Middle East and Africa.
Active medical implantable devices segment in Middle East & Africa region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing number of active medical implantable devices manufacturers and R&D activities. South Africa is leading the growth of the Middle East & Africa active medical implantable devices market and cardiovascular segment is dominating in this country due to increase in incidence of disease in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East & Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising new product developments are boosting the market growth of active medical implantable devices
Middle East & Africa Active medical implantable devices market also provides you with detailed market analysis for every country growth in active medical implantable devices industry with Active medical implantable devices drugs sales, impact of advancement in the active medical implantable devices technology and changes in regulatory scenarios with their support for the market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Active medical implantable devices Market Share Analysis
Active medical implantable devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus related to Active medical implantable devices market.
The major companies which are dealing in the Middle East and Africa active medical implantable devices market are NeuroPace, Inc., Axonics, Inc., Stimwave LLC, NEVRO CORP, Second Sight, BIOTRONIK, ABIOMED, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler., Sonova, MED-EL Medical Electronics among others.
Several product launches and agreements are also initiated by the companies worldwide, which are also accelerating the growth of the active medical implantable devices market.
For instance,
- In August 2020, Medtronic announced the acquisition of Companion Medical, a private company manufacturer of InPen. This will expand the company’s ability to better serve people with diabetes.
- In July 2021, Abbott announced the launch of insert able cardiac monitor, Jot Dx in U.S. The device helps clinicians to view abnormal heart rhythm and allows for remote detection and improved diagnosis accuracy of cardiac arrhythmia. This will help the company to further acquire the market in coming years.
SKU-